This recall involves The Vitamin Shoppe’s Vthrive Bioactive Women’s One-Daily Multivitamins. The 60-count capsules were sold in an amber bottle with a gray top. Vthrive and Bioactive Women’s One-Daily Multi are printed on a blue label on the bottle. Item number VS-6104
Massachusetts Attorney General Maura Healey has reached an $11 million settlement with an Andover mail-order pharmacy over allegations the company had a role in shipping thousands of illegitimate opioid painkiller prescriptions around the country. The allegations involve Injured Workers Pharmacy (IWP) in
West Virginia Attorney General Patrick Morrisey filed two lawsuits against Walgreens and Rite Aid this week, claiming they failed to monitor and report suspicious orders of controlled substances and ordered excessive amounts of opioids to their pharmacies in the state. In the
Immediately after the FDA said it found elevated levels of the carcinogenic ingredient N-nitrosodimethylamine (NDMA) in certain extended release (ER) metformin products, the first 2 major recalls are underway. Both Apotex Corp and Amneal Pharmaceuticals have issued a voluntary recall of its metformin hydrochloride extended-release
The FDA (Food and Drug Administration) has recently upgraded the recall of Alere INRatio and INRatio2 Monitor systems to a Class I recall. This means that there is a probability that using the Alere system will cause serious health consequences or possibly lead to death.
According to the Boston Globe, on at least two occasions in the past decade, Massachusetts pharmacy officials have displayed indifference in their supervision of a concerning Framingham compounding pharmacy (The New England Compounding Center) that is linked to the nationwide meningitis outbreak that has killed
The sister company of Framingham’s New England Compounding Center (NECC) – Ameridose – recalled all of its products on October 31, 2012. According to health officials, the NECC is the source of fungus-contaminated steroid injections that have killed 28 people and sickened at least 363
In 2004, Massachusetts health regulators proposed a formal reprimand for the pharmacy that is currently linked to the deadly nationwide meningitis outbreak – the New England Compounding Center (NECC) in Framingham, Massachusetts. Health officials never delivered the reprimand, however, after the company protested the
On Monday, October 15, U.S. health regulators announced that two other drugs produced by the New England Compounding Center (NECC), of Framingham, Massachusetts, may be linked to the meningitis outbreak. According to the Food and Drug Administration (FDA), there is an ongoing investigation of
On October 10, an agreement with the Department of Public Health’s Board of Registration in Pharmacy was signed, stating that Ameridose and its distribution partner, Alanaus Pharmaceuticals, are voluntarily shutting down operations until October 22 to allow inspectors the access needed to conduct an investigation.
New England Compounding Center (NECC) shares the same owners as Ameridose, a company licensed and regulated by federal authorities to manufacture medications on a large scale. Until June 2011, Ameridose’s headquarters were right around the corner from NECC in Framingham, Massachusetts. Government investigators have to
U.S. health officials announced on Monday, October 8, that 13,000 patients in 23 states, including Connecticut, New Hampshire, and Rhode Island, have been exposed to a potentially hazardous steroid treatment manufactured by a Framingham compounding company. The medication has been linked to a national